© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Doctors Without Borders

Generic Hepatitis, HIV and TB Treatments Could Plunge to $90 Each

Such generic drugs could save nations huge sums in the coming years.

Patent Challenges in India and Argentina Target Hepatitis C Treatment

Their aim is to help remove existing barriers to the production and distribution of generic HCV treatment around the world.

Battle Over Patent of Hepatitis C Treatment Begins in India

Lawyers argue that the formula for sofosbuvir was based on “old science” and that the patent should be rejected.

Fighting For Global Access to Hepatitis C Therapies

Battle lines are drawn as the global health community prepares to face off with Big Pharma over the astronomic cost of treatment.

Gilead Is First Drug Company to Join Medicines Patent Pool

Gilead Sciences has expanded its global access program for HBV in developing countries by joining medicines patent pool.
Advertisement

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.